- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Sectors
Glycomine glides to $68m series B round
Mission Bay Capital, the venture capital arm of California Institute for Quantitative Biosciences, helped the replacement therapy developer close its series B round.
Jun 24, 2021Boston Scientific bonds with Farapulse for $295m
Long-term investor Boston Scientific is paying $295m upfront for the 73% of the ablation technology developer it does not own.
Jun 24, 2021Confluent concocts $828m initial public offering
LinkedIn's data streaming spinoff, Confluent, is floating above its range in an offering effectively doubling the valuation of its last funding round to over $9bn.
Jun 24, 2021Soulgate shuts off IPO plans
The Tencent-backed social media app developer was aiming to raise $198m in the offering but has withdrawn in favour of alternative financing options.
Jun 24, 2021Blockchain Capital locks in corporates for $300m fund
PayPal and Visa have backed Blockchain Capital’s fifth flagship fund, which received $300m of commitments and which will focus on blockchain technology and cryptocurrencies.
Jun 24, 2021Konfio hauls in $125m through series E
Internet and telecommunications group SoftBank took part in the round, which will fund the business finance provider's acquisition strategy.
Jun 24, 2021Aircall surpasses $1bn valuation with $120m series D
Deutsche Telekom Capital Partners invested in a series D round for the call centre technology provider led by Goldman Sachs Asset Management.
Jun 24, 2021Glycomine glides to $68m series B round
Sanofi Ventures co-led replacement therapy developer Glycomine's latest round, which included Novo, Asahi Kasei Pharma Ventures and Chiesi Ventures.
Jun 24, 2021ImmuneID nets $50m in series A
Alexandria Venture Investments backed precision immunology therapeutics developer ImmuneID in the round, which was led by venture capital firm Alta Partners.
Jun 24, 2021Nostromo lists shares through Somoto merger
Shell, Taavura Group and Menora Mivtachim-backed Nostromo secured $13.6m through a reverse merger with publicly-listed Somoto.
Jun 24, 2021Farapulse finds $295m exit
Boston Scientific has acquired all remaining shares in its portfolio company Farapulse, having first invested in the University of Iowa spinout in 2014.
Jun 24, 2021LinkedCare leverages strategic investors in series D
Sheng Ye Capital and existing investor So-Young participated in a round for the medical supplies ordering platform sized at a minimum of $70m.
Jun 24, 2021Featured Content
The CVC Funding Round DatabaseRealtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.The CVC Funding Round Database
Realtime data of all startup funding rounds with corporate backers. Full access for GCV+ subscribers.
CVC DirectoryFull details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.CVC Directory
Full details of 600+ CVC units globally, including key people, sector focus, preferred investment stage and more. ull access for GCV+ subscribers.
Corporate venture building reportData from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomesCorporate venture building report
Data from 100+ corporate venture building programmes, including size, budgets, staffing, reporting lines and outcomes
About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
